Related Experiment Video
Updated: Jun 20, 2026

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model
Published on: April 16, 2014
Orexins/hypocretins and orexin receptors in apoptosis: a mini-review
M Laburthe1, T Voisin, A El Firar
1INSERM U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Paris, France. marc.laburthe@inserm.fr
Abstract:
An unexpected and fascinating aspect of the neuropeptides orexins has recently emerged when it was shown that orexins acting at orexin receptors OX1R or OX2R induce dramatic apoptosis resulting in massive reduction in cell growth in various cancer cell lines. This mini-review will provide the reader with recent findings related to the proapoptotic actions of orexins and the entirely novel mechanism whereby the seven membrane-spanning G-protein-coupled receptor (GPCR) OX1R triggers apoptosis. Recent data show that orexins induce tyrosine phosphorylation of the tyrosine-based motifs - immunoreceptor tyrosine-based inhibitory motif and immunoreceptor tyrosine-based switch motif - in OX1R. These phosphorylations result in the recruitment and activation of the phosphotyrosine phosphatase SHP-2 and subsequent cytochrome c-mediated mitochondrial apoptosis. Finally, this mini-review will also speculate on: (1) the potential importance of tyrosine-based motifs in the large family of GPCRs; (2) the interest of orexin receptors as therapeutic targets in cancer therapy; (3) the possible role of orexin receptor-mediated apoptosis in physiology and pathophysiology in the brain (neurodevelopment, neurodegenerative diseases) and in the periphery.
Insights
Orexins trigger cancer cell death by inducing apoptosis through orexin receptors. This novel mechanism involves tyrosine phosphorylation and SHP-2 activation, offering potential cancer therapy targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Neuroscience
Background:
- Neuropeptides orexins are known for regulating sleep-wake cycles.
- Emerging research reveals orexins' role in inducing apoptosis in cancer cells.
Purpose of the Study:
- To review recent findings on the pro-apoptotic actions of orexins.
- To elucidate the novel mechanism of orexin receptor OX1R-mediated apoptosis.
- To explore therapeutic potential and broader physiological roles of orexin receptors.
Main Methods:
- Review of recent scientific literature on orexin signaling and cancer.
- Analysis of molecular mechanisms involving orexin receptors (OX1R/OX2R) and apoptosis pathways.
- Investigation of tyrosine phosphorylation, SHP-2 phosphatase, and mitochondrial apoptosis.
Main Results:
- Orexins induce significant apoptosis and reduce cancer cell growth via OX1R and OX2R.
- A novel pathway involves orexin-induced tyrosine phosphorylation of motifs in OX1R.
- This leads to SHP-2 recruitment, activation, and subsequent cytochrome c-mediated mitochondrial apoptosis.
Conclusions:
- Orexin receptors represent a novel therapeutic target for cancer treatment.
- Tyrosine-based motifs in G-protein-coupled receptors (GPCRs) may have broader significance.
- Orexin receptor-mediated apoptosis could play roles in neurodevelopment, neurodegeneration, and peripheral physiology.
Related Concept Videos
Apoptosis
The Intrinsic Apoptotic Pathway
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
The Extrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy

